Natco Pharma - News
NSE: NATCOPHARM | BSE: 524816
₹841.50
As on 31-Aug-2026IST
Market cap
₹15,086 Cr
Revenue (TTM)
₹3,485 Cr
P/E Ratio
13.2
P/B Ratio
1.6
Div. Yield
0.6 %
Quarterly Updates
Annual Reports
NSE: NATCOPHARM | BSE: 524816
₹841.50
As on 31-Aug-2026IST
Market cap
₹15,086 Cr
Revenue (TTM)
₹3,485 Cr
P/E Ratio
13.2
P/B Ratio
1.6
Div. Yield
0.6 %
Annual Reports